Home
Conditions
Neurofibromatoses

Clinical trial condition

Neurofibromatoses

Explore clinical trials studying Neurofibromatoses. Study availability and eligibility vary by location and protocol.

143 public trials 20 recruiting studies

Refine in advanced search Browse all conditions

Neurofibromatoses trial results

Completed

AZD2014 In NF2 Patients With Progressive or Symptomatic Meningiomas

NCT02831257

Conditions: Central Nervous System Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, +30 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors

NCT02415153

Conditions: Central Nervous System Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, +33 more
Locations: Children's Hospital Los Angeles Los Angeles, California, United States

Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States

Children's National Medical Center Washington D.C., District of Columbia, United States

Lurie Children's Hospital-Chicago Chicago, Illinois, United States

View Trial Details

Completed

Efficacy of Computerized Cognitive Training and Stimulant Medication in Neurofibromatosis Type 1

NCT02944032

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +14 more
Locations: Children's National Health System Washington D.C., District of Columbia, United States

View Trial Details

Completed

Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

NCT02129647

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +29 more
Locations: NYU Langone Medical Center New York, United States

View Trial Details

Completed

Icotinib Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors

NCT02934256

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +29 more
Locations: Beijing Tiantan Hospital Affiliated to Capital Medical University Beijing, Beijing Municipality, China

Beijing Tiantan Hospital Affiliated to Capital Medical University Beijing, China

View Trial Details

Completed

Mechanism of Action of Transcranial Direct Current Stimulation in Neurofibromatosis Type 1

NCT04991428

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +13 more
Locations: University of Manchester Manchester, Greater Manchester, United Kingdom

View Trial Details

Completed

From Molecules to Cognition: Inhibitory Mechanisms in ASD and NF1

NCT03826940

Conditions: Autism Spectrum Disorder, Behavior, Child Development Disorders, Pervasive, +19 more
Locations: ICNAS Coimbra, Portugal

View Trial Details

Completed

Effects of Physical Training on Bone and Muscle Quality, Muscle Strength, and Motor Coordination in Children With NF1

NCT01058330

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +14 more
Locations: Shriners Hospitals for Children, Salt Lake City Salt Lake City, Utah, United States

University of Utah Salt Lake City, Utah, United States

View Trial Details

Completed

A Single Center Pilot Study to Assess the Intra-observer Reliability of Measuring Muscle Strength Using a Hand Held Dynamometer in Children and Adults With Neurofibromatosis Type 1 (NF1) and Type 2 (NF2)

NCT03672838

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +28 more
Locations: New York School of Medicine New York, United States

View Trial Details

Completed

Whole-body Vibration in Children With Neurofibromatosis Type 1

NCT03888248

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +22 more
Locations: Manchester University Hospitals NHS Foundation Trust Manchester, United Kingdom

View Trial Details

Neurofibromatoses

Neurofibromatoses trial results

Related conditions